Rocha, G.; Francés-Gómez, C.; MegÃas, J.; Muñoz-Hidalgo, L.; Casanova, P.; Haro-Estevez, J.F.; Teruel-MartÃ, V.; Monleón, D.; San-Miguel, T.
Isocitrate Dehydrogenase-Wildtype Glioma Adapts Toward Mutant Phenotypes and Enhanced Therapy Sensitivity Under D-2-Hydroxyglutarate Exposure. Biomedicines 2025, 13, 1584.
https://doi.org/10.3390/biomedicines13071584
AMA Style
Rocha G, Francés-Gómez C, MegÃas J, Muñoz-Hidalgo L, Casanova P, Haro-Estevez JF, Teruel-Martà V, Monleón D, San-Miguel T.
Isocitrate Dehydrogenase-Wildtype Glioma Adapts Toward Mutant Phenotypes and Enhanced Therapy Sensitivity Under D-2-Hydroxyglutarate Exposure. Biomedicines. 2025; 13(7):1584.
https://doi.org/10.3390/biomedicines13071584
Chicago/Turabian Style
Rocha, Geraldine, Clara Francés-Gómez, Javier MegÃas, Lisandra Muñoz-Hidalgo, Pilar Casanova, Jose F. Haro-Estevez, Vicent Teruel-MartÃ, Daniel Monleón, and Teresa San-Miguel.
2025. "Isocitrate Dehydrogenase-Wildtype Glioma Adapts Toward Mutant Phenotypes and Enhanced Therapy Sensitivity Under D-2-Hydroxyglutarate Exposure" Biomedicines 13, no. 7: 1584.
https://doi.org/10.3390/biomedicines13071584
APA Style
Rocha, G., Francés-Gómez, C., MegÃas, J., Muñoz-Hidalgo, L., Casanova, P., Haro-Estevez, J. F., Teruel-MartÃ, V., Monleón, D., & San-Miguel, T.
(2025). Isocitrate Dehydrogenase-Wildtype Glioma Adapts Toward Mutant Phenotypes and Enhanced Therapy Sensitivity Under D-2-Hydroxyglutarate Exposure. Biomedicines, 13(7), 1584.
https://doi.org/10.3390/biomedicines13071584
